Prehospital Deaths From Spontaneous Subarachnoid Haemorrhages
NCT ID: NCT04052646
Last Updated: 2020-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
58 participants
OBSERVATIONAL
2019-09-13
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Presentation of Subarachnoid Haemorrhage
NCT03980613
Long-term Effects of Time to Treatment in Subarachnoid Haemorrhage
NCT04377347
Time to Specialized Admission in Case of Severe Brain Haemorrhage.
NCT03786068
Cerebral Nitrosative/Oxidative Stress in Aneurysmal Subarachnoid Haemorrhage
NCT05686265
SpareBrain - Mechanisms and Prevention of Secondary Brain Injury in Subarachnoid Haemorrhage
NCT02026596
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While some patients may die at onset of the hemorrhage, others may have experienced symptoms longer. The clinical presentation of sSAH varies and some studies report as little as 40% of patients to have presented with classic textbook symptoms. Half are initially in an intact neurological state. These patients may have been in contact with the health care system but not admitted.
In recent years the Copenhagen Emergency Medical Coordinations Center has implemented an electronic decision support tool. If this has reduced the proportion of patients with sSAH that die outside hospital is unknown.
Primary aim:
The primary aim of this study is to determine the incidence of fatal spontaneous subarachnoid hemorrhage in the Capital Region of Denmark, before being admitted to hospital.
Secondary analyses:
* Proportion of deceased patients that have been in contact with a general practitioner, on-call general practitioner, the Copenhagen Emergency Medical Services or admitted to hospital within 72 hours of their death.
* Proportion of deceased patients with a history of significant illness immediately before their dead, but without contacting the health care system.
* For patients in contact with the Copenhagen Emergency Medical Services, their primary complaint and the initiated response.
* Descriptive characteristics of deceased with respect to age, gender, body mass index and comorbidities.
* Time trends in the incidence of prehospital death from sSAH over the years 2008-2017.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Medical condition: Subarachnoid hemorrhage
We identify patients with the condition of interest and retrospectively collect data on them.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Asger Sonne, MD
Clinical assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STPS 3-3013-2985/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.